Impact of immune system humanization on atherosclerosis in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice

F. Bonacina, J. Nour, A. Moregola, Gianluigi Inzoli, O. Terenghi, Francesca Fantini, G. Norata
{"title":"Impact of immune system humanization on atherosclerosis in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice","authors":"F. Bonacina, J. Nour, A. Moregola, Gianluigi Inzoli, O. Terenghi, Francesca Fantini, G. Norata","doi":"10.56095/eaj.v2i1.38","DOIUrl":null,"url":null,"abstract":"Aim: Given the key role of the immune response during atherosclerosis and the therapeutic interest of biologics targeting human immune cells, the need of experimental models to translate molecular mechanisms and to test therapeutic approaches for atherosclerosis is continuously increasing. Here we describe the characteristics of an innovative immunodeficient mouse humanized with hCD34+ cells on an atheroprone background. Methods: LDLR-KO mice were crossed with the immunodeficient C57BL/6J strain Rag2-KO/IL2rg-KO/CD47-KO (TKO, IMSR_JAX:025730) to generate an immunocompromised dyslipidemic mouse TKO-LDLR KO recipient of human hematopoietic stem cells (hCD34+). Results: TKO-LDLR KO were first characterized for their immune and metabolic profile. TKO mice are deficient in mature lymphocytes and NK cells and this profile was conserved in TKO-LDLR KO mice. Under high cholesterol diet for 8 weeks, both males and females TKO-LDLR KO present monocytosis with increased levels of Ly6Chi monocytes compared to TKO-LDLR KO at standard diet, develop marked dyslipidemia (total cholesterol 870.9 and 890.1 mg/dL male and females respectively), steatosis and atherosclerosis. This profile confirms the suitability of TKO-LDLR KO mice for atherosclerosis studies. Next, we tested the impact of immune system humanization. TKO-LDLR KO pups received a low-dose irradiation (150-200 cGy) and thereafter 1,5-2 x 10^5 hCD34+ were injected with in the liver. Engraftment of human leukocytes (hCD45+) was evaluated after two months by flow cytometry analysis from tail blood. This approach allows to reconstitute between 10-30% of hCD45+, mainly B and T cells. Conclusions: We have generated and characterized for the first time a humanized dyslipidemic TKO-LDLR KO mouse. This mouse model presents human B and T cells and could represent an important tool to investigate the impact of biologics targeted toward human targets in the context of atherosclerosis.","PeriodicalId":227903,"journal":{"name":"European Atherosclerosis Journal","volume":"90 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Atherosclerosis Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56095/eaj.v2i1.38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Given the key role of the immune response during atherosclerosis and the therapeutic interest of biologics targeting human immune cells, the need of experimental models to translate molecular mechanisms and to test therapeutic approaches for atherosclerosis is continuously increasing. Here we describe the characteristics of an innovative immunodeficient mouse humanized with hCD34+ cells on an atheroprone background. Methods: LDLR-KO mice were crossed with the immunodeficient C57BL/6J strain Rag2-KO/IL2rg-KO/CD47-KO (TKO, IMSR_JAX:025730) to generate an immunocompromised dyslipidemic mouse TKO-LDLR KO recipient of human hematopoietic stem cells (hCD34+). Results: TKO-LDLR KO were first characterized for their immune and metabolic profile. TKO mice are deficient in mature lymphocytes and NK cells and this profile was conserved in TKO-LDLR KO mice. Under high cholesterol diet for 8 weeks, both males and females TKO-LDLR KO present monocytosis with increased levels of Ly6Chi monocytes compared to TKO-LDLR KO at standard diet, develop marked dyslipidemia (total cholesterol 870.9 and 890.1 mg/dL male and females respectively), steatosis and atherosclerosis. This profile confirms the suitability of TKO-LDLR KO mice for atherosclerosis studies. Next, we tested the impact of immune system humanization. TKO-LDLR KO pups received a low-dose irradiation (150-200 cGy) and thereafter 1,5-2 x 10^5 hCD34+ were injected with in the liver. Engraftment of human leukocytes (hCD45+) was evaluated after two months by flow cytometry analysis from tail blood. This approach allows to reconstitute between 10-30% of hCD45+, mainly B and T cells. Conclusions: We have generated and characterized for the first time a humanized dyslipidemic TKO-LDLR KO mouse. This mouse model presents human B and T cells and could represent an important tool to investigate the impact of biologics targeted toward human targets in the context of atherosclerosis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
免疫系统人源化对血脂异常Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO小鼠动脉粥样硬化的影响
目的:鉴于免疫反应在动脉粥样硬化中的关键作用以及针对人类免疫细胞的生物制剂的治疗兴趣,对实验模型的需求不断增加,以翻译分子机制和测试动脉粥样硬化的治疗方法。在这里,我们描述了在动脉粥样硬化背景下用hCD34+细胞人源化的创新性免疫缺陷小鼠的特征。方法:将LDLR-KO小鼠与免疫缺陷的C57BL/6J株Rag2-KO/IL2rg-KO/CD47-KO (TKO, IMSR_JAX:025730)杂交,生成免疫功能低下的血脂异常小鼠TKO- LDLR-KO受体人造血干细胞(hCD34+)。结果:TKO-LDLR KO首次被鉴定为免疫和代谢特征。TKO小鼠缺乏成熟淋巴细胞和NK细胞,这种情况在TKO- ldlr KO小鼠中保持不变。高胆固醇饮食8周后,与标准饮食的TKO-LDLR KO相比,男性和女性TKO-LDLR KO均出现单核细胞增多,Ly6Chi单核细胞水平升高,出现明显的血脂异常(男性和女性总胆固醇分别为870.9和890.1 mg/dL),脂肪变性和动脉粥样硬化。这证实了TKO-LDLR KO小鼠在动脉粥样硬化研究中的适用性。接下来,我们测试了免疫系统人性化的影响。TKO-LDLR KO幼崽接受低剂量(150-200 cGy)照射后,肝脏注射1,5-2 × 10^5 hCD34+。2个月后用尾血流式细胞术分析人白细胞(hCD45+)的植入情况。这种方法允许重组10-30%的hCD45+,主要是B细胞和T细胞。结论:我们首次产生并鉴定了人源化的血脂异常TKO-LDLR KO小鼠。该小鼠模型呈现人类B细胞和T细胞,可能是研究动脉粥样硬化背景下针对人类靶点的生物制剂影响的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of Clinical Features including the frequency of Familial Hypercholesterolemia, and 2-Year Cardiovascular Outcomes in Patients with Early Acute Coronary Syndrome: Real-Life Data from a Retrospective Cohort PCSK9 in extrahepatic tissues: What can we expect from its inhibition? Statin-Associated Muscle Symptoms: Clinical Index in a hypertensive population candidated to lipid-lowering therapy but not taking statins Optimization of glucose control drives improvement of NAFLD independent of weight loss in people with T2D Impact of immune system humanization on atherosclerosis in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1